Likewise, the SOD activity was significantly increased at 15 and 35 days after transplanting in the MS treatment, but at 25 days after transplanting, we observed no significant differences in SOD activity compared to CK (Fig. 3B). This evidence concerns the gene SOD1 and myeloid sarcoma.